Future Approaches in Periodontal Regeneration: Gene Therapy, Stem Cells, and RNA Interference

Dental Clinics of North America

Volumn 54, Issue 1, 2010, Pages 141-155

  Intini, Giuseppe ^a  

^a HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

Gene therapy; Periodontal regeneration; Periodontal therapy; RNA interference; Stem cells

Indexed keywords

ANIMAL; BONE DEVELOPMENT; BONE REGENERATION; GENE THERAPY; GENETICS; HUMAN; PERIODONTAL DISEASE; PHYSIOLOGY; REGENERATION; REVIEW; RNA INTERFERENCE; STEM CELL TRANSPLANTATION;

ANIMALS; BONE REGENERATION; GENE THERAPY; HUMANS; OSTEOGENESIS; PERIODONTAL ATTACHMENT LOSS; REGENERATION; RNA INTERFERENCE; STEM CELL TRANSPLANTATION;

EID: 73249124771     PISSN: 00118532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cden.2009.09.002     Document Type: Review

References (99)

1. Oliver R.C., Brown L.J., and Loe H. Periodontal diseases in the United States population. J Periodontol 69 2 (1998) 269-278
2. Scannapieco F.A., and Panesar M. Periodontitis and chronic kidney disease. J Periodontol 79 9 (2008) 1617-1619
3. Friedewald V.E., Kornman K.S., Beck J.D., et al. The American Journal of Cardiology and Journal of Periodontology editors' consensus: periodontitis and atherosclerotic cardiovascular disease (diamond). J Periodontol 80 7 (2009) 1021-1032
4. Paju S., and Scannapieco F.A. Oral biofilms, periodontitis, and pulmonary infections. Oral Dis 13 6 (2007) 508-512
5. Scannapieco F.A. Systemic effects of periodontal diseases. Dent Clin North Am 49 3 (2005) 533-550 vi
6. Tezal M., Sullivan M.A., Reid M.E., et al. Chronic periodontitis and the risk of tongue cancer. Arch Otolaryngol Head Neck Surg 133 5 (2007) 450-454
7. Nevins M., Giannobile W.V., McGuire M.K., et al. Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial. J Periodontol 76 12 (2005) 2205-2215
8. Taba Jr. M., Jin Q., Sugai J.V., et al. Current concepts in periodontal bioengineering. Orthod Craniofac Res 8 4 (2005) 292-302
9. Salgado A.J., Coutinho O.P., and Reis R.L. Bone tissue engineering: state of the art and future trends. Macromol Biosci 4 8 (2004) 743-765
10. Franceschi R.T. Biological approaches to bone regeneration by gene therapy. J Dent Res 84 12 (2005) 1093-1103
11. Cheema S.K., Chen E., Shea L.D., et al. Regulation and guidance of cell behavior for tissue regeneration via the siRNA mechanism. Wound Repair Regen 15 3 (2007) 286-295
12. Yao Y., Wang C., Varshney R.R., et al. Antisense makes sense in engineered regenerative medicine. Pharm Res 26 2 (2009) 263-275
13. Lattanzi W., Pola E., Pecorini G., et al. Gene therapy for in vivo bone formation: recent advances. Eur Rev Med Pharmacol Sci 9 3 (2005) 167-174
14. Luo J., Sun M.H., Kang Q., et al. Gene therapy for bone regeneration. Curr Gene Ther 5 2 (2005) 167-179
15. Phillips J.E., Gersbach C.A., and Garcia A.J. Virus-based gene therapy strategies for bone regeneration. Biomaterials 28 2 (2007) 211-229
16. Zhao M., Zhao Z., Koh J.T., et al. Combinatorial gene therapy for bone regeneration: cooperative interactions between adenovirus vectors expressing bone morphogenetic proteins 2, 4, and 7. J Cell Biochem 95 1 (2005) 1-16
17. Hacein-Bey-Abina S., von Kalle C., Schmidt M., et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 348 3 (2003) 255-256
18. Noguchi P. Risks and benefits of gene therapy. N Engl J Med 348 3 (2003) 193-194
19. Vigna E., and Naldini L. Lentiviral vectors: excellent tools for experimental gene transfer and promising candidates for gene therapy. J Gene Med 2 5 (2000) 308-316
20. Partridge K.A., and Oreffo R.O. Gene delivery in bone tissue engineering: progress and prospects using viral and nonviral strategies. Tissue Eng 10 1-2 (2004) 295-307
21. Oligino T.J., Yao Q., Ghivizzani S.C., et al. Vector systems for gene transfer to joints. Clin Orthop Relat Res 379 Suppl (2000) S17-S30
22. Wolff J.A. Naked DNA transport and expression in mammalian cells. Neuromuscul Disord 7 5 (1997) 314-318
23. Templeton N.S., and Lasic D.D. New directions in liposome gene delivery. Mol Biotechnol 11 2 (1999) 175-180
24. Franceschi R.T., Wang D., Krebsbach P.H., et al. Gene therapy for bone formation: in vitro and in vivo osteogenic activity of an adenovirus expressing BMP7. J Cell Biochem 78 3 (2000) 476-486
25. Bonadio J. Tissue engineering via local gene delivery. J Mol Med 78 6 (2000) 303-311
26. Bonadio J., Smiley E., Patil P., et al. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat Med 5 7 (1999) 753-759
27. Shea L.D., Smiley E., Bonadio J., et al. DNA delivery from polymer matrices for tissue engineering. Nat Biotechnol 17 6 (1999) 551-554
28. Ramseier C.A., Abramson Z.R., Jin Q., et al. Gene therapeutics for periodontal regenerative medicine. Dent Clin North Am 50 2 (2006) 245-263 ix
29. Giannobile W.V., Lee C.S., Tomala M.P., et al. Platelet-derived growth factor (PDGF) gene delivery for application in periodontal tissue engineering. J Periodontol 72 6 (2001) 815-823
30. Zhu Z., Lee C.S., Tejeda K.M., et al. Gene transfer and expression of platelet-derived growth factors modulate periodontal cellular activity. J Dent Res 80 3 (2001) 892-897
31. Anusaksathien O., Webb S.A., Jin Q.M., et al. Platelet-derived growth factor gene delivery stimulates ex vivo gingival repair. Tissue Eng 9 4 (2003) 745-756
32. Jin Q., Anusaksathien O., Webb S.A., et al. Engineering of tooth-supporting structures by delivery of PDGF gene therapy vectors. Mol Ther 9 4 (2004) 519-526
33. Jin Q.M., Anusaksathien O., Webb S.A., et al. Gene therapy of bone morphogenetic protein for periodontal tissue engineering. J Periodontol 74 2 (2003) 202-213
34. Lieberman J.R., Daluiski A., Stevenson S., et al. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J Bone Joint Surg Am 81 7 (1999) 905-917
35. Baltzer A.W., Lattermann C., Whalen J.D., et al. Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene. Gene Ther 7 9 (2000) 734-739
36. Cheng S.L., Lou J., Wright N.M., et al. In vitro and in vivo induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene. Calcif Tissue Int 68 2 (2001) 87-94
37. Lee J.Y., Musgrave D., Pelinkovic D., et al. Effect of bone morphogenetic protein-2-expressing muscle-derived cells on healing of critical-sized bone defects in mice. J Bone Joint Surg Am 83-A 7 (2001) 1032-1039
38. Musgrave D.S., Bosch P., Ghivizzani S., et al. Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone. Bone 24 6 (1999) 541-547
39. Koh J.T., Zhao Z., Wang Z., et al. Combinatorial gene therapy with BMP2/7 enhances cranial bone regeneration. J Dent Res 87 9 (2008) 845-849
40. Edwards P.C., Ruggiero S., Fantasia J., et al. Sonic hedgehog gene-enhanced tissue engineering for bone regeneration. Gene Ther 12 1 (2005) 75-86
41. Lee J.Y., Peng H., Usas A., et al. Enhancement of bone healing based on ex vivo gene therapy using human muscle-derived cells expressing bone morphogenetic protein 2. Hum Gene Ther 13 10 (2002) 1201-1211
42. Berry M., Gonzalez A.M., Clarke W., et al. Sustained effects of gene-activated matrices after CNS injury. Mol Cell Neurosci 17 4 (2001) 706-716
43. Geiger F., Bertram H., Berger I., et al. Vascular endothelial growth factor gene-activated matrix (VEGF165-GAM) enhances osteogenesis and angiogenesis in large segmental bone defects. J Bone Miner Res 20 11 (2005) 2028-2035
44. Guo T., Zeng X., Hong H., et al. Gene-activated matrices for cartilage defect reparation. Int J Artif Organs 29 6 (2006) 612-621
45. Endo M., Kuroda S., Kondo H., et al. Bone regeneration by modified gene-activated matrix: effectiveness in segmental tibial defects in rats. Tissue Eng 12 3 (2006) 489-497
46. Termaat M.F., Den Boer F.C., Bakker F.C., et al. Bone morphogenetic proteins: development and clinical efficacy in the treatment of fractures and bone defects. J Bone Joint Surg Am 87 6 (2005) 1367-1378
47. Wilson J.M. Medicine: a history lesson for stem cells. Science 324 5928 (2009) 727-728
48. Lin N.H., Gronthos S., and Bartold P.M. Stem cells and periodontal regeneration. Aust Dent J 53 2 (2008) 108-121
49. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 282 5391 (1998) 1145-1147
50. Mitjavila-Garcia M.T., Simonin C., and Peschanski M. Embryonic stem cells: meeting the needs for cell therapy. Adv Drug Deliv Rev 57 13 (2005) 1935-1943
51. Baum C.M., Weissman I.L., Tsukamoto A.S., et al. Isolation of a candidate human hematopoietic stem-cell population. Proc Natl Acad Sci U S A 89 7 (1992) 2804-2808
52. Slack J.M. Stem cells in epithelial tissues. Science 287 5457 (2000) 1431-1433
53. Uchida N., Buck D.W., He D., et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A 97 26 (2000) 14720-14725
54. Castro-Malaspina H., Gay R.E., Resnick G., et al. Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 56 2 (1980) 289-301
55. Campagnoli C., Roberts I.A., Kumar S., et al. Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98 8 (2001) 2396-2402
56. van Imhoff G.W., van der Holt B., Mackenzie M.A., et al. Short intensive sequential therapy followed by autologous stem cell transplantation in adult Burkitt, Burkitt-like and lymphoblastic lymphoma. Leukemia 19 6 (2005) 945-952
57. Song K.W., Barnett M.J., Gascoyne R.D., et al. Haematopoietic stem cell transplantation as primary therapy of sporadic adult Burkitt lymphoma. Br J Haematol 133 6 (2006) 634-637
58. Bruder S.P., Kurth A.A., Shea M., et al. Bone regeneration by implantation of purified, culture-expanded human mesenchymal stem cells. J Orthop Res 16 2 (1998) 155-162
59. Mankani M.H., Kuznetsov S.A., Shannon B., et al. Canine cranial reconstruction using autologous bone marrow stromal cells. Am J Pathol 168 2 (2006) 542-550
60. Kon E., Muraglia A., Corsi A., et al. Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. J Biomed Mater Res 49 3 (2000) 328-337
61. Robey P.G., Kuznetsov S.A., Riminucci M., et al. Skeletal (mesenchymal) stem cells for tissue engineering. Methods Mol Med 140 (2007) 83-99
62. Bianco P., and Robey P.G. Stem cells in tissue engineering. Nature 414 6859 (2001) 118-121
63. Gurdon J.B., and Melton D.A. Nuclear reprogramming in cells. Science 322 5909 (2008) 1811-1815
64. Wilmut I., Beaujean N., de Sousa P.A., et al. Somatic cell nuclear transfer. Nature 419 6907 (2002) 583-586
65. Takahashi K., and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 4 (2006) 663-676
66. Yamanaka S. A fresh look at iPS cells. Cell 137 1 (2009) 13-17
67. Kim J.B., et al. Oct4-induced pluripotency in adult neural stem cells. Cell 136 3 (2009) 411-419
68. Yu J., Hu K., Smuga-Otto K., et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 324 5928 (2009) 797-801
69. Okita K., Nakagawa M., Hyenjong H., et al. Generation of mouse induced pluripotent stem cells without viral vectors. Science 322 5903 (2008) 949-953
70. Huangfu D., Osafune K., Maehr R., et al. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat Biotechnol 26 11 (2008) 1269-1275
71. Shi Y., Desponts C., Do J.T., et al. Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 3 5 (2008) 568-574
72. Weintraub H., Tapscott S.J., Davis R.L., et al. Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. Proc Natl Acad Sci U S A 86 14 (1989) 5434-5438
73. Zhou Q., Brown J., Kanarek A., et al. In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature 455 7213 (2008) 627-632
74. Gould T.R., Melcher A.H., and Brunette D.M. Migration and division of progenitor cell populations in periodontal ligament after wounding. J Periodontal Res 15 1 (1980) 20-42
75. Isaka J., Ohazama A., Kobayashi M., et al. Participation of periodontal ligament cells with regeneration of alveolar bone. J Periodontol 72 3 (2001) 314-323
76. McCulloch C.A., and Bordin S. Role of fibroblast subpopulations in periodontal physiology and pathology. J Periodontal Res 26 3 Pt 1 (1991) 144-154
77. Seo B.M., Miura M., Gronthos S., et al. Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet 364 9429 (2004) 149-155
78. Gronthos S., Mrozik K., Shi S., et al. Ovine periodontal ligament stem cells: isolation, characterization, and differentiation potential. Calcif Tissue Int 79 5 (2006) 310-317
79. Shi S., Bartold P.M., Miura M., et al. The efficacy of mesenchymal stem cells to regenerate and repair dental structures. Orthod Craniofac Res 8 3 (2005) 191-199
80. Chen S.C., Marino V., Gronthos S., et al. Location of putative stem cells in human periodontal ligament. J Periodontal Res 41 6 (2006) 547-553
81. Lin N.H., Menicanin D., Mrozik K., et al. Putative stem cells in regenerating human periodontium. J Periodontal Res 43 5 (2008) 514-523
82. Robey P.G., and Bianco P. The use of adult stem cells in rebuilding the human face. J Am Dent Assoc 137 7 (2006) 961-972
83. Flores M.G., Hasegawa M., Yamato M., et al. Cementum-periodontal ligament complex regeneration using the cell sheet technique. J Periodontal Res 43 3 (2008) 364-371
84. Nakahara T., Nakamura T., Kobayashi E., et al. In situ tissue engineering of periodontal tissues by seeding with periodontal ligament-derived cells. Tissue Eng 10 3-4 (2004) 537-544
85. Yang Z., Jin F., Zhang X., et al. Tissue engineering of cementum/periodontal-ligament complex using a novel three-dimensional pellet cultivation system for human periodontal ligament stem cells. Tissue Eng Part C Methods (2009) PMID: 19534606 [Epub ahead of print]
86. Yamada Y., Ueda M., Hibi H., et al. A novel approach to periodontal tissue regeneration with mesenchymal stem cells and platelet-rich plasma using tissue engineering technology: a clinical case report. Int J Periodontics Restorative Dent 26 4 (2006) 363-369
87. Kitoh H., Kitakoji T., Tsuchiya H., et al. Transplantation of culture expanded bone marrow cells and platelet rich plasma in distraction osteogenesis of the long bones. Bone 40 2 (2007) 522-528
88. Fire A., Xu S., Montgomery M.K., et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391 6669 (1998) 806-811
89. Castanotto D., and Rossi J.J. The promises and pitfalls of RNA-interference-based therapeutics. Nature 457 7228 (2009) 426-433
90. Elbashir S.M., Harborth J., Lendeckel W., et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411 6836 (2001) 494-498
91. Mocellin S., and Provenzano M. RNA interference: learning gene knock-down from cell physiology. J Transl Med 2 1 (2004) 39
92. Shen J., Samul R., Silva R.L., et al. Suppression of ocular neovascularization with siRNA targeting VEGF receptor 1. Gene Ther 13 3 (2006) 225-234
93. Mocellin S., Costa R., and Nitti D. RNA interference: ready to silence cancer?. J Mol Med 84 1 (2006) 4-15
94. Li S.D., Chonoc S., and Huang L. Efficient oncogene silencing and metastasis inhibition via systemic delivery of siRNA. Mol Ther 16 5 (2008) 942-946
95. Natarajan R., Salloum F.N., Fisher B.J., et al. Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury. Circ Res 98 1 (2006) 133-140
96. Chen L.X., Lin L., Wang H.J., et al. Suppression of early experimental osteoarthritis by in vivo delivery of the adenoviral vector-mediated NF-kappaBp65-specific siRNA. Osteoarthritis Cartilage 16 2 (2008) 174-184
97. Zwicky R., Müntener K., Goldring M.B., et al. Cathepsin B expression and down-regulation by gene silencing and antisense DNA in human chondrocytes. Biochem J 367 Pt 1 (2002) 209-217
98. Dong L., Wang R., Zhu Y.A., et al. Antisense oligonucleotide targeting TNF-alpha can suppress Co-Cr-Mo particle-induced osteolysis. J Orthop Res 26 8 (2008) 1114-1120
99. Gazzerro E., Smerdel-Ramoya A., Zanotti S., et al. Conditional deletion of gremlin causes a transient increase in bone formation and bone mass. J Biol Chem 282 43 (2007) 31549-31557